Express Scripts Holding Co.  (ESRX)
Other Ticker:  

Express Scripts Holding Co's



ESRX Sales vs. its Competitors Q3 2018

Comparing the results to its competitors, Express Scripts Holding Co reported Total Revenue increase in the 3 quarter 2018 by 3.56 % year on year.
The revenue growth was below Express Scripts Holding Co's competitors average revenue growth of 6.14 %, recorded in the same quarter.

List of ESRX Competitors

With net margin of 4.2 % company achieved higher profitability than its competitors.

More on ESRX Margin Comparisons

Revenue Growth Comparisons

Net Income Comparison

Express Scripts Holding Co. Net Income in the 3 quarter 2018 grew year on year by 27.08 %, slower than its competitors income growth of 71.32 %

<<  More on ESRX Income Comparisons

Express Scripts Holding Co's Comment on Competitors and Industry Peers

There are a number of other PBMs in the United States against which we compete. Some of these are independent PBMs, such as Catamaran and MedImpact. Others are owned by managed care organizations such as Aetna Inc., CIGNA Corporation, Humana, OptumRx (owned by UnitedHealth Group) and Prime Therapeutics (owned by a collection of Blue Cross Blue Shield Plans). Some are owned by retail pharmacies, such as CVS Caremark (owned by CVS).

Wal-Mart Stores, Inc. may continue to engage in certain activities competitive with PBMs. We also compete against adjudicators, such as Argus. With the emergence of alternative benefit models through Private Exchanges, the competitive landscape also includes brokers, health plans and consultants. Some of these competitors may have greater financial, marketing and technological resources.

In addition, other companies may enter into the business and become increasingly competitive as barriers to entry are relatively low. We believe the primary competitive factors in the industry include the ability to contract with retail pharmacies to ensure our retail pharmacy networks meet the needs of our clients and their members, the ability to negotiate discounts on prescription drugs with drug manufacturers, the ability to navigate the complexities of governmental reimbursed business, including Medicare Part D, Medicaid and the Public Exchanges, the ability to manage cost and quality of specialty drugs, the ability to utilize the information we obtain about drug utilization patterns and consumer behavior to reduce costs for our clients and members, and the level of service that we provide.


Overall company Market Share Q3 2018

Overall company revenue, grew less, than total compay revenues, at 3.56 % and company approximate market share, declined to 16.83 %.
<<  More on ESRX Market Share.
*Market share is calculated based on total revenue.

ESRX's vs. Competition, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

(in millions of $)
(in millions of $)
(in millions of $)
Express Scripts Holding Co. ESRX 52,360.34 100,179.00 4,607.00 29,500
Cvs Health Corporation CVS 140,462 307,860.00 8,157.00 290,000
Cardinal Health Inc. CAH 19,618 181,364.00 -932.00 48,000
Amerisourcebergen Corp ABC 32,277 236,325.28 1,804.31 22,000
Allscripts Healthcare Solutions Inc. MDRX 2,077 1,054.54 62.29 8,900
Optimizerx Corp OPRX 283 64.15 -6.98 23
SUBTOTAL 247,077.68 826,847.07 13,691.92 398,423

Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

SHAP's Profile

Stock Price

SHAP's Financials

Business Description


Charts & Quotes

SHAP's News


SHAP's Competitors

Customers & Markets

Economic Indicators

SHAP's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries






About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071